Chinese Journal of Antituberculosis ›› 2018, Vol. 40 ›› Issue (11): 1164-1169.doi: 10.3969/j.issn.1000-6621.2018.11.004
• Original Articles • Previous Articles Next Articles
AN Xiao-ying,YANG Yong-hui,ZHU Gui-yun,FANG Peng,BAI Hong-zhong,ZHANG Zhi-hua()
Received:
2018-08-27
Online:
2018-11-10
Published:
2018-12-04
Contact:
Xiao-ying AN,Zhi-hua ZHANG
E-mail:xkyy1128@163.com
AN Xiao-ying,YANG Yong-hui,ZHU Gui-yun,FANG Peng,BAI Hong-zhong,ZHANG Zhi-hua. Diagnostic value of Mycobacterium tuberculosis antigen 85B and early secreted antigenic target 6-kDa antigen fusion protein for tuberculous pleurisy[J]. Chinese Journal of Antituberculosis, 2018, 40(11): 1164-1169. doi: 10.3969/j.issn.1000-6621.2018.11.004
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2018.11.004
[1] |
Porcel JM . Tuberculous pleural effusion. Lung, 2009,187(5):263-270.
doi: 10.1007/s00408-009-9165-3 URL |
[2] |
孟苏凯, 吴振萍, 钟达 . 全血γ-干扰素释放试验在诊断结核分枝杆菌感染中的应用价值. 中国防痨杂志, 2015,37(12):1217-1220.
doi: 10.3969/j.issn.1000-6621.2015.12.009 URL |
[3] |
Levine H, Szanto PB, Cugell DW . Tuberculous pleurisy. An acute illness. Arch Intern Med, 2016,122(4):329-332.
doi: 10.1001/archinte.1968.00300090039009 URL pmid: 5676418 |
[4] |
Nishimura T, Hasegawa N, Mori M , et al. Accuracy of an interferon-gamma release assay to detect active pulmonary and extra-pulmonary tuberculosis. Int J Tuberc Lung Dis, 2008,12(3):269-274.
doi: 10.1258/ijsa.2007.007310 URL pmid: 18284831 |
[5] | 宋雪娜, 杨华, 刘君 . Th1/Th2免疫应答平衡在结核性和恶性肿瘤性胸腔积液中的意义. 中国肿瘤临床与康复, 2014,21(9):1052-1054. |
[6] |
王洁玲, 唐余燕, 张毅 , 等. 结核分枝杆菌抗原Ag85B优势诱导活动性结核患者Th1型细胞免疫反应研究. 医学研究杂志, 2016,45(3):77-82.
doi: 10.11969/j.issn.1673-548X.2016.03.021 URL |
[7] |
Kuo CJ, Bell H, Hsieh CL , et al. Novel mycobacteria antigen 85 complex binding motif on fibronectin. J Biol Chem, 2012,287(3):1892-1902.
doi: 10.1074/jbc.M111.298687 URL |
[8] |
Qiao D, Yang BY, Li L , et al. ESAT-6 and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection. Scand J Immunol, 2011,73(4):330-337.
doi: 10.1111/j.1365-3083.2011.02512.x URL pmid: 21223348 |
[9] | 中华医学会. 临床诊疗指南·结核病分册. 北京: 人民卫生出版社, 2005. |
[10] |
刘建利, 师长宏, 靳亚平 , 等. 结核分枝杆菌Ag85B与ESAT6融合蛋白的表达、纯化及抗原活性的初步研究. 中国人兽共患病学报, 2009,25(5):449-452.
doi: 10.3969/j.issn.1002-2694.2009.05.013 URL |
[11] |
孔忠顺, 刘京铭, 高孟秋 . 结核性胸膜炎诊断的研究进展. 中国防痨杂志, 2016,38(4):327-330.
doi: 10.3969/j.issn.1000-6621.2016.04.020 URL |
[12] |
Ates G, Yildiz T, Ortakoylu MG , et al. Adapted T cell interferon-gamma release assay for the diagnosis of pleural tuberculosis. Respiration, 2011,82(4):351-357.
doi: 10.1159/000323184 URL pmid: 21293103 |
[13] |
Liu F, Gao M, Zhang X , et al. Interferon-gamma release assay performance of pleural fluid and peripheral blood in pleural tuberculosis. PLoS One, 2013,8(12):e83857.
doi: 10.1371/journal.pone.0083857 URL pmid: 3873962 |
[14] |
Yamashita Y, Hoshino Y, Oka M , et al. Multicolor flow cytometric analyses of CD4+ T cell responses to Mycobacterium tuberculosis-related latent antigens . JPN J Infect Dis, 2013,66(66):207-215.
doi: 10.7883/yoken.66.207 URL pmid: 23698481 |
[15] | Green AM, Difazio R, Flynn JL . IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection. J Immunol, 2012,190(1):270-277. |
[16] | 柴雪敏, 黎友伦 . 结核分枝杆菌Ag85复合物相关疫苗研究进展. 中国防痨杂志, 2013,35(4):282-285. |
[17] |
Ping W, Limei W, Wei Z , et al. Immunotherapeutic efficacy of recombinant Mycobacterium smegmatis expressing Ag85B-ESAT6 fusion protein against persistent tuberculosis infection in mice. Human Vaccines, 2013,10(1):150-158.
doi: 10.4161/hv.26171 URL pmid: 23982126 |
[18] | 何宗林, 杜先智 . ESAT6在结核病中的最新研究进展. 国际检验医学杂志, 2011,32(6):663-665. |
[19] |
van Dissel JT, Soonawala D, Joosten SA , et al. Ag85B-ESAT-6 adjuvanted with IC31 ® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection . Vaccine, 2011,29(11):2100-2109.
doi: 10.1016/j.vaccine.2010.02.094 URL pmid: 20226890 |
[20] | 姜德华 . 结核分枝杆菌融合蛋白疫苗(Ag85B-ESAT6)的构建及免疫学特性研究. 长春:吉林大学, 2010. |
[21] |
You Q, Wu Y, Jiang D , et al. Immune responses induced by heterologous boosting of recombinant bacillus Calmette-Guerin with Ag85B-ESAT6 fusion protein in levamisole-based adjuvant. Immunol Invest, 2012,41(4):412-428.
doi: 10.3109/08820139.2012.658940 URL pmid: 22360290 |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||